Forian Inc ( (FORA) ) has released its Q1 earnings. Here is a breakdown of the information Forian Inc presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Forian Inc. is a prominent provider of data science-driven information and analytics solutions, catering to the life sciences, healthcare, and financial services sectors. The company is known for its expertise in managing and commercializing large-scale healthcare data assets.
In its first quarter of 2025, Forian Inc. reported a significant increase in revenue, marking a 45% rise compared to the previous year. This growth is attributed to strategic acquisitions, contract renewals, and the integration of new data feeds, despite the ongoing macroeconomic uncertainties.
Key financial highlights include a revenue of $7.1 million, up from $4.9 million in the same quarter last year, and a net loss of $1.1 million, slightly improved from the previous year’s $1.2 million. The company’s adjusted EBITDA showed a decline, reflecting increased investments and integration costs. Forian also expanded its presence in the pharmaceutical sector, benefiting from the adoption of its data solutions.
Looking ahead, Forian Inc. anticipates its revenue for the full year 2025 to range between $28 million and $30 million, with adjusted EBITDA expected to be between ($1.0) million and $1.0 million. The company remains optimistic about expanding its market share and enhancing its impact across the healthcare industry.